Adjuvant Chemotherapy in Node-Negative Advanced Gastric Cancer Patients

Table 3

Adverse events of the chemotherapy group (n = 169).

	All grades	Grade 3 or 4
Patients with ≥1 adverse event	135 (79.9%)	65 (38.5%)
Nausea	110 (65.1%)	13 (7.7%)
Neutropenia	101 (59.8%)	32 (18.9%)
Decreased appetite	100 (59.2%)	9 (5.3%)
Peripheral neuropathy	25 (14.8%)	3 (1.8%)
Diarrhoea	32 (18.9%)	4 (2.4%)
Vomiting	81 (47.9%)	9 (5.3%)
Fatigue	52 (30.8%)	8 (4.7%)
Thrombocytopenia	31 (18.3%)	12 (7.1%)
Hand-foot syndrome	20 (11.8%)	2 (1.2%)
Abdominal pain	23 (13.6%)	3 (1.8%)
Stomatitis	18 (10.7%)	1 (0.6%)